Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1989-2-7
|
pubmed:abstractText |
Forty-four patients with clear cell adenocarcinoma of the ovary diagnosed between 1944 and 1981 were compared with a matched cohort of 55 patients with the most common epithelial malignant lesion, serous adenocarcinoma, in terms of their presentation and clinical course. None were lost to follow-up. Median follow-up was 9 years. Fifty percent of clear cell patients presented in Stage I versus 31% of serous patients. Patients with clear cell carcinoma presented more often with pelvic masses (84% vs 65%) and had larger (diameter greater than 10 cm) primary tumors (73% vs 29%). Forty-nine percent of clear cell patients were nulligravid compared with 24% of serous patients and endometriosis was strikingly more common in clear cell patients (58% vs 12%). When compared stage for stage, clear cell tumors were uniformly associated with poorer 5-year survival rates with an overall rate of 34%. In patients with recurrent disease, lymph node involvement was much more common in patients with clear cell carcinoma (40% vs 7%). Parenchymal organ involvement was also more common in the clear cell group (40% vs 13%). Ovarian clear cell adenocarcinoma has distinctly different clinical behavior compared to serous carcinoma and should be regarded as an aggressive epithelial histologic type.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0090-8258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
65-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2642454-Actuarial Analysis,
pubmed-meshheading:2642454-Adenocarcinoma,
pubmed-meshheading:2642454-Adult,
pubmed-meshheading:2642454-Aged,
pubmed-meshheading:2642454-Cystadenocarcinoma,
pubmed-meshheading:2642454-Endometriosis,
pubmed-meshheading:2642454-Female,
pubmed-meshheading:2642454-Follow-Up Studies,
pubmed-meshheading:2642454-Humans,
pubmed-meshheading:2642454-Lymphatic Metastasis,
pubmed-meshheading:2642454-Middle Aged,
pubmed-meshheading:2642454-Neoplasm Recurrence, Local,
pubmed-meshheading:2642454-Neoplasm Staging,
pubmed-meshheading:2642454-Ovarian Neoplasms,
pubmed-meshheading:2642454-Prognosis,
pubmed-meshheading:2642454-Retrospective Studies
|
pubmed:year |
1989
|
pubmed:articleTitle |
Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts 02115.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review,
Research Support, Non-U.S. Gov't
|